Healthcare
ScripsAmerica, Inc.(SCRCQ)
Live Price
Offline$0.0001
+0.00% today
1Y Change
+0.00%
Window
Jun 23, 2025 โ Jun 18, 2026
- Market Cap
- โ
- Revenue Growth
- +5447.5%
- EPS Growth
- +76.8%
- Dividend Yield
- 0.0%
Coverage: 249 bars ยท Jun 23, 2025 โ Jun 18, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
ScripsAmerica, Inc. (SCRCQ) is a Healthcare stock with listed on OTC. The stock last traded around $0.00 and up 0.0% across the available one-year price window (Jun 23, 2025 โ Jun 18, 2026). Baseline metrics include revenue growth of +5447.5%, EPS growth of +76.8%, a dividend yield of 0.0%. What stands out right now is revenue +5447.5%, EPS +76.8%, free cash flow +132.5% with operating margin -12.3% and ROIC 388.0%. Valuation is more restrained than many high-expectation growth names at price/sales 0.0. Overall, the current profile looks closer to a higher-growth but lower-margin setup than a generic broad-market placeholder. Stock Foundry combines SCRCQ price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Above sector median
+5447.5% vs +7.6% peer median
Operating Margin
Below sector median
-12.3% vs +19.4% peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report is on the board
2016 was reported on Apr 4, 2016, but the surprise data is still limited.
The operating story is still moving forward
Revenue is running at +5447.5% and EPS at +76.8%, with operating margin around -12.3%.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 3 reported quarters, the stock averaged 0.0% over the next 5 trading days and finished higher after 0 of those reports.
View quarter-by-quarter reaction table
| Quarter | EPS ฮ | 1D | 5D | 20D |
|---|---|---|---|---|
2016 Apr 4, 2016 | โ | +0.0% | +0.0% | +0.0% |
2016 Jan 29, 2016 | โ | +0.0% | +0.0% | +0.0% |
2015 Mar 31, 2015 | โ | +0.0% | +0.0% | +0.0% |
Benchmark Comparison
Normalized Performance vs SPY
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
SCRCQ
โ
Normalized return
SPY
โ
S&P 500
Excess Return
โ
Relative to SPY
SCRCQ Max Drawdown
0.00%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for SCRCQ and SPY.
Company Overview
ScripsAmerica, Inc.
Other OTC
ScripsAmerica, Inc. develops and sells non-sterile topical and transdermal pain creams. The company also provides pharmacy dispensing services for individual doctors, as well as billing and administrative services to independent pharmacies. In addition, it distributes pharmaceutical products to independent pharmacies and other medical providers. The company was founded in 2008 and is based in Clifton, New Jersey. On February 8, 2017, the voluntary petition of ScripsAmerica, Inc. for reorganization under Chapter 11 was converted to Chapter 7. It had filed for Chapter 11 bankruptcy on September 7, 2016.
- Leadership
- Brian Ettinger
- IPO Date
- Jul 19, 2012
- Employees
- 21
- Street Address
- 1094 Main Avenue
- Mailing
- Clifton, NJ, 07011
- Region
- Clifton, NJ, US
- Reporting Currency
- USD
- Investor Line
- 800-957-7622
- Last Updated
- May 4, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- โ
- EV/EBITDA
- โ
- Price/Sales
- 0.0
- Price/Book
- โ
Growth
- Revenue
- +5447.5%
- EPS
- +76.8%
- Free Cash Flow
- +132.5%
Profitability
- Gross Margin
- 89.4%
- Operating Margin
- -12.3%
- Net Margin
- -15.3%
- ROE
- 162.6%
- ROIC
- 388.0%
Balance Sheet
- Debt/Equity
- โ
- Current Ratio
- 0.67
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.